IP Library Assignment 069197/0672
Patent Assignment
Reel/Frame 069197/0672

Release of Security Interest

Recorded: 2024-11-11 Pages: 10
Assignor
BIOPHARMA CREDIT PLC
Executed: 2024-11-08
Assignee
IMMUNOCORE LIMITED
92 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHI, OX144RY, UNITED KINGDOM
Covered Properties (12)
Methods of Treating Melanoma Using Tebentafusp and Immune Checkpoint Inhibitors
Soluble T Cell Receptor
Patent: 7,329,731 →
Application: 10/486,924 →
Publication: US 2005/0009025
Soluble T Cell Receptors
Patent: 7,763,718 →
Application: 11/926,391 →
Publication: US 2008/0153131
Bifunctional Polypeptides
Application: 13/319,597 →
Publication: US 2012/0190828
Non-naturally occurring T cell receptors
Patent: 8,519,100 →
Application: 13/342,579 →
Publication: US 2012/0225481
Nucleic Acid Molecules Encoding Non-Naturally Occurring T Cell Receptors and Cells Thereof
Patent: 9,068,178 →
Application: 13/947,580 →
Publication: US 2014/0099699
Bifunctional Polypeptides
Application: 16/151,144 →
Publication: US 2019/0247512
Dosing Regimen for GP100-Specific Tcr - Anti-CD3 Scfv Fusion Protein
Application: 16/305,838 →
Publication: US 2020/0040055
Bifunctional Polypeptides
Application: 16/378,481 →
Publication: US 2019/0231895
Bifunctional Polypeptides
Application: 16/378,501 →
Publication: US 2019/0275165
Bifunctional Polypeptides
Application: 16/378,505 →
Publication: US 2019/0231896
Formulations
Application: 17/423,843 →
Publication: US 2022/0080030
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 1, 2004
From: JAKOBSEN, BENT KARSTEN; GLICK, MEIR
To: AVIDEX LIMITED
Reel/Frame 015800/0973 →
Change of Name Nov 12, 2007
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 020097/0212 →
Assignment of Assignor's Interest Jan 8, 2009
From: MEDIGENE LIMITED
To: IMMUNOCORE LIMITED
Reel/Frame 022076/0044 →
Change of Name Feb 20, 2012
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 027731/0117 →
Assignment of Assignor's Interest Feb 20, 2012
From: JAKOBSEN, BENT KARSTEN; GLICK, MEIR
To: AVIDEX LIMITED
Reel/Frame 027731/0073 →
Assignment of Assignor's Interest Apr 5, 2012
From: JAKOBSEN, BENT KARSTEN; VUIDEPOT, ANNELISE BRIGITTE; LI, YI
To: IMMUNOCORE LIMITED
Reel/Frame 027995/0465 →
Assignment of Assignor's Interest Feb 7, 2013
From: JAKOBSEN, BENT KARSTEN; HARWOOD, NAOMI; LIDDY, NATHANIEL ROSS
To: IMMUNOCORE LIMITED
Reel/Frame 029769/0388 →
Assignment of Assignor's Interest Jul 18, 2013
From: IMMUNOCORE LIMITED
To: ADAPTIMMUNE LIMITED; IMMUNOCORE LIMITED
Reel/Frame 030824/0150 →
Assignment of Assignor's Interest Aug 4, 2014
From: JAKOBSEN, BENT KARSTEN; HARWOOD, NAOMI; LIDDY, NATHANIEL ROSS
To: IMMUNOCORE LTD.
Reel/Frame 033454/0314 →
Assignment of Assignor's Interest Oct 4, 2018
From: JAKOBSEN, BENT KARSTEN; VUIDEPOT, ANNELISE BRIGITTE; LI, YI
To: IMMUNOCORE LIMITED
Reel/Frame 047073/0370 →
Assignment of Assignor's Interest Jul 15, 2019
From: LI, YI; JAKOBSEN, BENT KARSTEN; VUIDEPOT, ANNELISE BRIGITTE
To: IMMUNOCORE LIMITED
Reel/Frame 049756/0895 →
Security Interest Nov 6, 2020
From: IMMUNOCORE LIMITED; IMMUNOCORE LLC; IMMUNOCORE COMMERCIAL LLC
To: OXFORD FINANCE LUXEMBOURG S.À R.L., REGISTERED WITH THE LUXEMBOURG COMMERCIAL REGISTER UNDER NUMBER B243395, ACTING IN RESPECT OF ITS COMPARTMENT 1
Reel/Frame 054344/0218 →
Corrective Assignment to Correct the Assignee Previously Recorded at Reel: 030824 Frame: 0150. Assignor(S) Hereby Confirms the Assignment. Nov 10, 2020
From: IMMUNOCORE LIMITED
To: IMMUNOCORE LIMITED; ADAPTIMMUNE LIMITED
Reel/Frame 054373/0041 →
Assignment of Assignor's Interest Nov 10, 2020
From: COUGHLIN, CHRISTINA
To: IMMUNOCORE LLC
Reel/Frame 054324/0320 →
Assignment of Assignor's Interest Nov 11, 2020
From: IMMUNOCORE LLC
To: IMMUNOCORE LIMITED
Reel/Frame 054341/0270 →
Assignment of Assignor's Interest Nov 19, 2021
From: JOHNSON, ANDY; EBNER, MARTIN; GRUDZIEN, LUKASZ
To: IMMUNOCORE LTD.
Reel/Frame 058167/0296 →
Patent Security Agreement Nov 8, 2022
From: IMMUNOCORE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 061899/0866 →
Release of Security Interest Nov 10, 2022
From: OXFORD FINANCE LUXEMBOURG S.À R.L
To: IMMUNOCORE LIMITED; IMMUNOCORE LLC; IMMUNOCORE COMMERCIAL LLC
Reel/Frame 061916/0493 →
Assignment of Assignor's Interest Sep 18, 2025
From: ADAPTIMMUNE LIMITED
To: IMMUNOCORE LIMITED
Reel/Frame 072896/0339 →